Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types
Angela L. Bosma(Amsterdam University Medical Centers), Maritza A. Middelkamp‐Hup(Amsterdam University Medical Centers), David Prieto‐Merino(London School of Hygiene & Tropical Medicine), Michael R. Ardern‐Jones, Nick J. Reynolds(Newcastle upon Tyne Hospitals NHS Foundation Trust), John R Ingram(Cardiff University), Carsten Flohr(King's College London), Wouter Ouwerkerk(University of Amsterdam), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Graham S. Ogg(University of Oxford), Richard Woolf(Guy's and St Thomas' NHS Foundation Trust), Phyllis I. Spuls, Alan D. Irvine(Trinity College Dublin), Richard B. Warren(Manchester Academic Health Science Centre), Sara Brown(University of Edinburgh), Madeline J. Heidema(Amsterdam UMC Location University of Amsterdam), Ariënna Hyseni(Amsterdam UMC Location University of Amsterdam), Prakash A. Patel(King's College London), Paula Beattie(Royal Hospital for Children), Ross Hearn(Ninewells Hospital), Mandy Wan(King's College London)
Cited by 10
Related Papers
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
|The Journal of Experimental Medicine|2000|864